Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Background and Purpose</h3><p>Microglia‐related inflammation is associated with the pathology of Parkinson's disease (PD). Functional voltage‐gated sodium channels (VGSCS) are involved in regulating microglial function. Here, we aim to investigate the effects of SVHRSP (scorpion venom heat‐resistant synthesized peptide) on 6‐OHDA‐induced PD‐like mouse model and reveal its underlying mechanism.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Experimental Approach</h3><p>Unilateral brain injection of 6‐OHDA was performed to establish PD mouse model. After behavior test, brain tissuses were collected for morphological analysis and protein/gene expression examination. Primary microglia culture was used to investigate the role of sodium channel Na<sub>v</sub>1.6 in the regulation of microglia inflammation by SVHRSP. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Key Results</h3><p>SVHRSP treatment attenuated motor deficits, dopaminergic neurodegeneration, activation of glial cells as well expression of pro‐inflammatory cytokines induced by 6‐OHDA lesion. Primary microglia activation and the production of pro‐inflammatory cytokines induced by lipopolysaccharide (LPS) were also suppressed by SVHRSP treatment. In addition, SVHRSP could inhibit mitogen‐activated protein kinases (MAPKs) pathway which plays pivotal roles in the pro‐inflammatory response. Notably, SVHRSP treatment suppressed the over‐expression of microglial Na<sub>v</sub>1.6 induced by 6‐OHDA and LPS. Finally, it was shown that the anti‐inflammatory effect of SVHRSP in microglia was Na<sub>v</sub>1.6 dependent and was related to suppression of sodium current and probably the consequent Na<sup>+</sup>/Ca<sup>2+</sup> exchange. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Conclusion and Implications</h3><p>SVHRSP might inhibit neuroinflammation and protect dopaminergic neurons via down‐regulating microglial Na<sub>v</sub>1.6 and subsequently suppressing intracellular Ca<sup>2+</sup> accumulation to attenuate the activation of MAPKs signaling pathway in microglia. </p></section>

Corrigendum: Scorpion Venom Heat-Resistant Peptide Attenuates Microglia Activation and Neuroinflammation

Corrigendum: Dl-3-n-Butylphthalide Exerts Dopaminergic Neuroprotection Through Inhibition of Neuroinflammation

Correction to: Inhibition of Dectin-1 Ameliorates Neuroinflammation by Regulating Microglia/Macrophage Phenotype After Intracerebral Hemorrhage in Mice

Corrigendum to “Lipopolysaccharide-Induced Podocyte Injury is Regulated by Calcineurin/nfat and TLR4/MyD88/NF-κB Signaling Pathways Through Angiopoietin-like Protein 4” [genes & Diseases 9(2022) 443–455]

Corrigendum: Alternative Splicing: a New Cause and Potential Therapeutic Target in Autoimmune Disease.

Corrigendum to “inhibiting Interleukin 17 Can Ameliorate the Demyelination Caused by A. Cantonensis Via Inos Inhibition”

Corrigendum: Ginsenoside Rg1 ameliorates neuroinflammation via suppression of connexin43 ubiquitination to attenuate depression

Corrigendum: Dauricine attenuates vascular endothelial inflammation through inhibiting NF-κB pathway.

Corrigendum: Combined Scutellarin and C18H17NO6 Imperils the Survival of Glioma: Partly Associated With the Repression of PSEN1/PI3K-AKT Signaling Axis

Corrigendum: Activation of EphrinB2/EphB2 signaling in the spine cord alters glia-neuron interactions in mice with visceral hyperalgesia following maternal separation

Corrigendum to “Macrophage membrane-coated nanocarriers Co-Modified by RVG29 and TPP improve brain neuronal mitochondria-targeting and therapeutic efficacy in Alzheimer's disease mice” [Bioactive materials 6 (2021) 529–542]

Erratum: CXCL12-mediated Monocyte Transmigration into Brain Perivascular Space Leads to Neuroinflammation and Memory Deficit in Neuropathic Pain: Erratum.

Corrigendum: Therapeutic potential of topical administration of acriflavine against hypoxia-inducible factors for corneal fibrosis

Corrigendum to “Antroquinonol Exerts Immunosuppressive Effect on CD8+ T Cell Proliferation and Activation to Resist Depigmentation Induced by H2O2”

Corrigendum to “maggot Extracts Alleviate Inflammation and Oxidative Stress in Acute Experimental Colitis Via the Activation of Nrf2”

Corrigendum: A Synthetic Small Molecule F240B Decreases NLRP3 Inflammasome Activation by Autophagy Induction

Corrigendum: Neuroprotective Effects of Celastrol on Transient Global Cerebral Ischemia Rats via Regulating HMGB1/NF-κB Signaling Pathway

Erratum: A thermosensitive, reactive oxygen species-responsive, MR409-encapsulated hydrogel ameliorates disc degeneration in rats by inhibiting the secretory autophagy pathway: Erratum

Corrigendum to "Atrase A, a P-III class metalloproteinase purified from cobra venom, exhibits potent anticoagulant activity by inhibiting coagulation pathway and activating the fibrinolytic system" [Heliyon Volume 10, Issue 10, 30 May 2024, Article e30969]

Corrigendum: Xiaoyaosan alleviates hippocampal glutamate-induced toxicity in the CUMS rats via NR2B and PI3K/Akt signaling pathway

Scorpion venom heat‐resistant synthesized peptide ameliorates 6‐OHDA‐induced neurotoxicity and neuroinflammation: likely role of Na v 1.6 inhibition in microglia